Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Joanna Chorostowska-Wynimko, Miriam Barrecheguren, Ilaria Ferrarotti, Timm Greulich, Robert A Sandhaus & Michael Campos. (2020) New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 345-355.
Read now
Read now
Jeanne Marie Perotin, Sylvie Leroy, Charles Hugo Marquette, Hervé Mal, Hervé Dutau, Arnaud Bourdin, Jean Michel Vergnon, Christophe Pison, Coralie Barbe & Gaëtan Deslee. (2018) Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3645-3649.
Read now
Read now
David G Parr & Beatriz Lara. (2017) Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature. Drug Design, Development and Therapy 11, pages 2149-2162.
Read now
Read now
Nikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, Martina Seibert, Stefan Wagenpfeil, Robert Bals & Sebastian Fähndrich. (2017) Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1427-1437.
Read now
Read now
Articles from other publishers (14)
Jean-François Mornex, Julie Traclet, Olivier Guillaud, Magali Dechomet, Christine Lombard, Mathias Ruiz, Didier Revel, Philippe Reix & Vincent Cottin. (2023) Alpha1-antitrypsin deficiency: An updated review. La Presse Médicale 52:3, pages 104170.
Crossref
Crossref
S.A. Papiris, M. Veith, A.I. Papaioannou, V. Apollonatou, I. Ferrarotti, S. Ottaviani, A. Tzouvelekis, V. Tzilas, N. Rovina, G. Stratakos, I. Gerogianni, Z. Daniil, L. Kolilekas, K. Dimakou, G. Pitsidianakis, N. Tzanakis, S. Tryfon, F. Fragopoulos, E.M. Antonogiannaki, A. Lazaratou, E. Fouka, D. Papakosta, P. Emmanouil, N. Anagnostopoulos, T. Karampitsakos, K. Vlami, M. Kallieri, P. Lyberopoulos, S. Loukides, D. Bouros, A. Bush, M. Balduyck, C. Lombard, V. Cottin, J.F. Mornex, C.F. Vogelmeier, T. Greulich & E.D. Manali. (2023) Alpha1-antitrypsin deficiency in Greece: Focus on rare variants. Pulmonology.
Crossref
Crossref
J.-F. Mornex. (2022) Le déficit en alpha 1-antitrypsine. Revue des Maladies Respiratoires 39:8, pages 698-707.
Crossref
Crossref
Marc Miravitlles, Mike Herepath, Asim Priyendu, Sheetal Sharma, Tatiana Vilchez, Oliver Vit, Michaela Haensel, Virginie Lepage, Helena Gens & Timm Greulich. (2022) Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews. European Respiratory Review 31:163, pages 210262.
Crossref
Crossref
Cláudia Henrique da Costa, Arnaldo José Noronha Filho, Rosa Maria Fernambel Marques e Silva, Thaís Ferrari da Cruz, Valeria de Oliveira Monteiro, Margareth Pio & Rogério Lopes Rufino. (2019) Alpha 1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease patients: is systematic screening necessary?. BMC Research Notes 12:1.
Crossref
Crossref
Ildikó Horváth, Maria Canotilho, Jan Chlumský, Joanna Chorostowska-Wynimko, Luciano Corda, Eric Derom, Joachim H. Ficker, Meinhard Kneussl, Marc Miravitlles, Maria Sucena, Gabriel Thabut, Alice M. Turner, Emily van ’t Wout & N. Gerard McElvaney. (2019)
Diagnosis and management of α
1
-antitrypsin deficiency in Europe: an expert survey
. ERJ Open Research 5:1, pages 00171-2018.
Crossref
Crossref
Franck F. Rahaghi & Marc Miravitlles. (2017) Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Respiratory Research 18:1.
Crossref
Crossref
G. Thabut. (2017) Cas clinique n° 4 : Emphysème et déficit en alpha-1 antitrypsine. Revue des Maladies Respiratoires Actualités 9:1, pages 29-31.
Crossref
Crossref
Margarida Torres Redondo, Elsa Campoa, Luis Ruano & Maria Sucena. (2017) Calidad de vida relacionada con la salud en pacientes con déficit de α1 antitripsina: estudio transversal. Archivos de Bronconeumología 53:2, pages 49-54.
Crossref
Crossref
Margarida Torres Redondo, Elsa Campoa, Luis Ruano & Maria Sucena. (2017) Health-Related Quality of Life in Patients With Alpha-1 Antitrypsin Deficiency: A Cross Sectional Study. Archivos de Bronconeumología (English Edition) 53:2, pages 49-54.
Crossref
Crossref
Ignacio Blanco. 2017. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Blanco's Overview of Alpha-1 Antitrypsin Deficiency
193
206
.
Ignacio Blanco. 2017. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Blanco's Overview of Alpha-1 Antitrypsin Deficiency
115
128
.
Ignacio Blanco. 2017. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Blanco's Overview of Alpha-1 Antitrypsin Deficiency
1
11
.
Kate McKeage & Katherine A. Lyseng-Williamson. (2016) Human α1-proteinase inhibitor (Respreeza®) in α1-antitrypsin deficiency emphysema: a guide to its use in the EU. Drugs & Therapy Perspectives 32:10, pages 422-427.
Crossref
Crossref